ABCC1 overexpression, also known as a multidrug resistance-associated protein-1 (MRP1), plays a crucial role in the failure of chemotherapy in a number of malignant tumors, including prostate, breast, and lung cancers [22,23,24,25]. Here, ABCC1 is linked to lung carcinoma.